DNA Q1 2021 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$44M+108.7% YoY

Gross Profit

$20M46.3% margin

Operating Income

-$57M-129.5% margin

Net Income

-$74M-166.8% margin

EPS (Diluted)

$-2.28

QoQ Revenue Growth

+37.6%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$70M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$643M

Total Liabilities

$248M

Stockholders' Equity

$388M

Cash & Equivalents

$308M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$21M	+108.7%
Gross Profit	$20M	$21M	-3.5%
Operating Income	-$57M	-$16M	-264.5%
Net Income	-$74M	-$25M	-194.6%